The aim of this study is to see if administering platelets (cells in our blood that stop or prevent bleeding) results in improved platelet function and slows/stops the progression of a head bleed for patients who have a traumatic head bleed and are on antiplatelet therapy (medications that stop blood cells from forming a blood clot) prior to admission.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Repeat TEG
Timeframe: 1 hour after platelets given
Repeat Head CT
Timeframe: From the time of interventional platelet administration until the time of patient discharge from their index admission, assessed up to 100 weeks.